The Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors

Background We investigated the role of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in predicting the effect of induction therapy in patients with thymic epithelial tumors. Methods Fourteen patients with thymic epithelial tumors who underwent PET-CT before and af...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of surgery 2017-07, Vol.41 (7), p.1828-1833
Hauptverfasser: Fukumoto, Koichi, Fukui, Takayuki, Okasaka, Toshiki, Kawaguchi, Koji, Nakamura, Shota, Hakiri, Shuhei, Ozeki, Naoki, Sugiyama, Tomoshi, Kato, Katsuhiko, Yokoi, Kohei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1833
container_issue 7
container_start_page 1828
container_title World journal of surgery
container_volume 41
creator Fukumoto, Koichi
Fukui, Takayuki
Okasaka, Toshiki
Kawaguchi, Koji
Nakamura, Shota
Hakiri, Shuhei
Ozeki, Naoki
Sugiyama, Tomoshi
Kato, Katsuhiko
Yokoi, Kohei
description Background We investigated the role of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in predicting the effect of induction therapy in patients with thymic epithelial tumors. Methods Fourteen patients with thymic epithelial tumors who underwent PET-CT before and after induction therapy were retrospectively analyzed. The relationship between the change in the maximum standardized uptake value (SUV max ) in PET-CT, the response evaluation criteria in solid tumors and the pathologic response (Ef0, no necrosis of tumor cells; Ef1, some necrosis of tumor cells with more than one-third of viable tumor cells; Ef2, less than one-third of tumor cells were viable; and Ef3, no tumor cells were viable) was analyzed. Results The study cohort consisted of 5 males and 9 females. Nine of the patients had thymoma, and 5 had thymic carcinoma. The induction therapy included chemotherapy in 9 cases, chemoradiation therapy in 4 cases and radiation therapy in 1 case. Among the 8 patients with a pathologic response of Ef0/1, 5 were clinically evaluated as having stable disease (SD), while 3 were found to have had a partial response (PR). The SUV max was elevated in 2 cases, unchanged in 1 and decreased in 5. On the other hand, 3 of the 6 patients with a pathologic response of Ef2, 3 were classified as having SD, while the other 3 had a PR. The SUV max decreased in all of the patients. Conclusions In comparison with CT, PET-CT seems to be useful for predicting the pathologic response to induction therapy in patients with thymic epithelial tumors.
doi_str_mv 10.1007/s00268-017-3938-2
format Article
fullrecord <record><control><sourceid>proquest_wiley</sourceid><recordid>TN_cdi_proquest_miscellaneous_1875141714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1875141714</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1261-43ed654e1c2e1446f1556116d83df5c35c913222b5028f41f2a91aed74cd6eea3</originalsourceid><addsrcrecordid>eNp1kcGO1DAQRC0EEsPAB3DzkUvAbSdO5riMZmDRSoyWII5WSDqJV0462ImWfBM_iUfZAxdO3WrVK6mrGHsL4j0IkX8IQkhdJALyRB1UkchnbAepkolUUj1nO6F0GndQL9mrEB5EFGqhd-xP2SO_J4ecWg7FOWndQp4apN9r55aaAvILBTt7GvlpsCHYuJQ0UOerqV-TIw3TMmPzz4235PnFY2Pr2Y4dv1RzT446W_N7DBON0fOmndHz27FZoubq2GNkN7Ts1yFqT5Ode3S2crxcBvLhNXvRVi7gm6e5Z9_Pp_L4Obn7-un2eHOXTCA1JKnCRmcpQi0R0lS3kGUaQDeFatqsVll9ACWl_JkJWbQptLI6QIVNntaNRqzUnr3bfCdPvxYMs4l_1-hcNSItwUCRZ5BCHvPds8MmfbQOVzN5O1R-NSDMtRWztWJi2ObaipHmx5dvH8-iULGJPZMbGyI2dujNAy1-jJ_9n1d_AXqwlgc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1875141714</pqid></control><display><type>article</type><title>The Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors</title><source>Wiley Online Library Journals Frontfile Complete</source><source>SpringerLink Journals</source><creator>Fukumoto, Koichi ; Fukui, Takayuki ; Okasaka, Toshiki ; Kawaguchi, Koji ; Nakamura, Shota ; Hakiri, Shuhei ; Ozeki, Naoki ; Sugiyama, Tomoshi ; Kato, Katsuhiko ; Yokoi, Kohei</creator><creatorcontrib>Fukumoto, Koichi ; Fukui, Takayuki ; Okasaka, Toshiki ; Kawaguchi, Koji ; Nakamura, Shota ; Hakiri, Shuhei ; Ozeki, Naoki ; Sugiyama, Tomoshi ; Kato, Katsuhiko ; Yokoi, Kohei</creatorcontrib><description>Background We investigated the role of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in predicting the effect of induction therapy in patients with thymic epithelial tumors. Methods Fourteen patients with thymic epithelial tumors who underwent PET-CT before and after induction therapy were retrospectively analyzed. The relationship between the change in the maximum standardized uptake value (SUV max ) in PET-CT, the response evaluation criteria in solid tumors and the pathologic response (Ef0, no necrosis of tumor cells; Ef1, some necrosis of tumor cells with more than one-third of viable tumor cells; Ef2, less than one-third of tumor cells were viable; and Ef3, no tumor cells were viable) was analyzed. Results The study cohort consisted of 5 males and 9 females. Nine of the patients had thymoma, and 5 had thymic carcinoma. The induction therapy included chemotherapy in 9 cases, chemoradiation therapy in 4 cases and radiation therapy in 1 case. Among the 8 patients with a pathologic response of Ef0/1, 5 were clinically evaluated as having stable disease (SD), while 3 were found to have had a partial response (PR). The SUV max was elevated in 2 cases, unchanged in 1 and decreased in 5. On the other hand, 3 of the 6 patients with a pathologic response of Ef2, 3 were classified as having SD, while the other 3 had a PR. The SUV max decreased in all of the patients. Conclusions In comparison with CT, PET-CT seems to be useful for predicting the pathologic response to induction therapy in patients with thymic epithelial tumors.</description><identifier>ISSN: 0364-2313</identifier><identifier>EISSN: 1432-2323</identifier><identifier>DOI: 10.1007/s00268-017-3938-2</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Abdominal Surgery ; Cardiac Surgery ; Chemoradiation Therapy ; General Surgery ; Induction Therapy ; Malignant Pleural Mesothelioma ; Medicine ; Medicine &amp; Public Health ; Original Scientific Report ; Pathologic Response ; Surgery ; Thoracic Surgery ; Thymoma ; Vascular Surgery</subject><ispartof>World journal of surgery, 2017-07, Vol.41 (7), p.1828-1833</ispartof><rights>Société Internationale de Chirurgie 2017</rights><rights>2017 The Author(s) under exclusive licence to Société Internationale de Chirurgie</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-p1261-43ed654e1c2e1446f1556116d83df5c35c913222b5028f41f2a91aed74cd6eea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00268-017-3938-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00268-017-3938-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,41464,42533,45550,45551,51294</link.rule.ids></links><search><creatorcontrib>Fukumoto, Koichi</creatorcontrib><creatorcontrib>Fukui, Takayuki</creatorcontrib><creatorcontrib>Okasaka, Toshiki</creatorcontrib><creatorcontrib>Kawaguchi, Koji</creatorcontrib><creatorcontrib>Nakamura, Shota</creatorcontrib><creatorcontrib>Hakiri, Shuhei</creatorcontrib><creatorcontrib>Ozeki, Naoki</creatorcontrib><creatorcontrib>Sugiyama, Tomoshi</creatorcontrib><creatorcontrib>Kato, Katsuhiko</creatorcontrib><creatorcontrib>Yokoi, Kohei</creatorcontrib><title>The Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors</title><title>World journal of surgery</title><addtitle>World J Surg</addtitle><description>Background We investigated the role of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in predicting the effect of induction therapy in patients with thymic epithelial tumors. Methods Fourteen patients with thymic epithelial tumors who underwent PET-CT before and after induction therapy were retrospectively analyzed. The relationship between the change in the maximum standardized uptake value (SUV max ) in PET-CT, the response evaluation criteria in solid tumors and the pathologic response (Ef0, no necrosis of tumor cells; Ef1, some necrosis of tumor cells with more than one-third of viable tumor cells; Ef2, less than one-third of tumor cells were viable; and Ef3, no tumor cells were viable) was analyzed. Results The study cohort consisted of 5 males and 9 females. Nine of the patients had thymoma, and 5 had thymic carcinoma. The induction therapy included chemotherapy in 9 cases, chemoradiation therapy in 4 cases and radiation therapy in 1 case. Among the 8 patients with a pathologic response of Ef0/1, 5 were clinically evaluated as having stable disease (SD), while 3 were found to have had a partial response (PR). The SUV max was elevated in 2 cases, unchanged in 1 and decreased in 5. On the other hand, 3 of the 6 patients with a pathologic response of Ef2, 3 were classified as having SD, while the other 3 had a PR. The SUV max decreased in all of the patients. Conclusions In comparison with CT, PET-CT seems to be useful for predicting the pathologic response to induction therapy in patients with thymic epithelial tumors.</description><subject>Abdominal Surgery</subject><subject>Cardiac Surgery</subject><subject>Chemoradiation Therapy</subject><subject>General Surgery</subject><subject>Induction Therapy</subject><subject>Malignant Pleural Mesothelioma</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Original Scientific Report</subject><subject>Pathologic Response</subject><subject>Surgery</subject><subject>Thoracic Surgery</subject><subject>Thymoma</subject><subject>Vascular Surgery</subject><issn>0364-2313</issn><issn>1432-2323</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kcGO1DAQRC0EEsPAB3DzkUvAbSdO5riMZmDRSoyWII5WSDqJV0462ImWfBM_iUfZAxdO3WrVK6mrGHsL4j0IkX8IQkhdJALyRB1UkchnbAepkolUUj1nO6F0GndQL9mrEB5EFGqhd-xP2SO_J4ecWg7FOWndQp4apN9r55aaAvILBTt7GvlpsCHYuJQ0UOerqV-TIw3TMmPzz4235PnFY2Pr2Y4dv1RzT446W_N7DBON0fOmndHz27FZoubq2GNkN7Ts1yFqT5Ode3S2crxcBvLhNXvRVi7gm6e5Z9_Pp_L4Obn7-un2eHOXTCA1JKnCRmcpQi0R0lS3kGUaQDeFatqsVll9ACWl_JkJWbQptLI6QIVNntaNRqzUnr3bfCdPvxYMs4l_1-hcNSItwUCRZ5BCHvPds8MmfbQOVzN5O1R-NSDMtRWztWJi2ObaipHmx5dvH8-iULGJPZMbGyI2dujNAy1-jJ_9n1d_AXqwlgc</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Fukumoto, Koichi</creator><creator>Fukui, Takayuki</creator><creator>Okasaka, Toshiki</creator><creator>Kawaguchi, Koji</creator><creator>Nakamura, Shota</creator><creator>Hakiri, Shuhei</creator><creator>Ozeki, Naoki</creator><creator>Sugiyama, Tomoshi</creator><creator>Kato, Katsuhiko</creator><creator>Yokoi, Kohei</creator><general>Springer International Publishing</general><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>The Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors</title><author>Fukumoto, Koichi ; Fukui, Takayuki ; Okasaka, Toshiki ; Kawaguchi, Koji ; Nakamura, Shota ; Hakiri, Shuhei ; Ozeki, Naoki ; Sugiyama, Tomoshi ; Kato, Katsuhiko ; Yokoi, Kohei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1261-43ed654e1c2e1446f1556116d83df5c35c913222b5028f41f2a91aed74cd6eea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Abdominal Surgery</topic><topic>Cardiac Surgery</topic><topic>Chemoradiation Therapy</topic><topic>General Surgery</topic><topic>Induction Therapy</topic><topic>Malignant Pleural Mesothelioma</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Original Scientific Report</topic><topic>Pathologic Response</topic><topic>Surgery</topic><topic>Thoracic Surgery</topic><topic>Thymoma</topic><topic>Vascular Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fukumoto, Koichi</creatorcontrib><creatorcontrib>Fukui, Takayuki</creatorcontrib><creatorcontrib>Okasaka, Toshiki</creatorcontrib><creatorcontrib>Kawaguchi, Koji</creatorcontrib><creatorcontrib>Nakamura, Shota</creatorcontrib><creatorcontrib>Hakiri, Shuhei</creatorcontrib><creatorcontrib>Ozeki, Naoki</creatorcontrib><creatorcontrib>Sugiyama, Tomoshi</creatorcontrib><creatorcontrib>Kato, Katsuhiko</creatorcontrib><creatorcontrib>Yokoi, Kohei</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>World journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fukumoto, Koichi</au><au>Fukui, Takayuki</au><au>Okasaka, Toshiki</au><au>Kawaguchi, Koji</au><au>Nakamura, Shota</au><au>Hakiri, Shuhei</au><au>Ozeki, Naoki</au><au>Sugiyama, Tomoshi</au><au>Kato, Katsuhiko</au><au>Yokoi, Kohei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors</atitle><jtitle>World journal of surgery</jtitle><stitle>World J Surg</stitle><date>2017-07</date><risdate>2017</risdate><volume>41</volume><issue>7</issue><spage>1828</spage><epage>1833</epage><pages>1828-1833</pages><issn>0364-2313</issn><eissn>1432-2323</eissn><abstract>Background We investigated the role of 18 F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) in predicting the effect of induction therapy in patients with thymic epithelial tumors. Methods Fourteen patients with thymic epithelial tumors who underwent PET-CT before and after induction therapy were retrospectively analyzed. The relationship between the change in the maximum standardized uptake value (SUV max ) in PET-CT, the response evaluation criteria in solid tumors and the pathologic response (Ef0, no necrosis of tumor cells; Ef1, some necrosis of tumor cells with more than one-third of viable tumor cells; Ef2, less than one-third of tumor cells were viable; and Ef3, no tumor cells were viable) was analyzed. Results The study cohort consisted of 5 males and 9 females. Nine of the patients had thymoma, and 5 had thymic carcinoma. The induction therapy included chemotherapy in 9 cases, chemoradiation therapy in 4 cases and radiation therapy in 1 case. Among the 8 patients with a pathologic response of Ef0/1, 5 were clinically evaluated as having stable disease (SD), while 3 were found to have had a partial response (PR). The SUV max was elevated in 2 cases, unchanged in 1 and decreased in 5. On the other hand, 3 of the 6 patients with a pathologic response of Ef2, 3 were classified as having SD, while the other 3 had a PR. The SUV max decreased in all of the patients. Conclusions In comparison with CT, PET-CT seems to be useful for predicting the pathologic response to induction therapy in patients with thymic epithelial tumors.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><doi>10.1007/s00268-017-3938-2</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0364-2313
ispartof World journal of surgery, 2017-07, Vol.41 (7), p.1828-1833
issn 0364-2313
1432-2323
language eng
recordid cdi_proquest_miscellaneous_1875141714
source Wiley Online Library Journals Frontfile Complete; SpringerLink Journals
subjects Abdominal Surgery
Cardiac Surgery
Chemoradiation Therapy
General Surgery
Induction Therapy
Malignant Pleural Mesothelioma
Medicine
Medicine & Public Health
Original Scientific Report
Pathologic Response
Surgery
Thoracic Surgery
Thymoma
Vascular Surgery
title The Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Predicting Pathologic Response After Induction Therapy for Thymic Epithelial Tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T02%3A50%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%2018F-fluorodeoxyglucose%20Positron%20Emission%20Tomography-Computed%20Tomography%20for%20Predicting%20Pathologic%20Response%20After%20Induction%20Therapy%20for%20Thymic%20Epithelial%20Tumors&rft.jtitle=World%20journal%20of%20surgery&rft.au=Fukumoto,%20Koichi&rft.date=2017-07&rft.volume=41&rft.issue=7&rft.spage=1828&rft.epage=1833&rft.pages=1828-1833&rft.issn=0364-2313&rft.eissn=1432-2323&rft_id=info:doi/10.1007/s00268-017-3938-2&rft_dat=%3Cproquest_wiley%3E1875141714%3C/proquest_wiley%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1875141714&rft_id=info:pmid/&rfr_iscdi=true